FeesSafety
Pluang+

OXB appoints Dr Joachim Kreuzburg as Independent Non-Executive Director to support growth strategy.

Company Fundamentals
16 Oct 2026, 18:00 WIB
Na
View Source
Bullish
OXB appoints Dr Joachim Kreuzburg as Independent Non-Executive Director to support growth strategy.

OXB, a global cell and gene therapy CDMO, has appointed Dr Joachim Kreuzburg as an Independent Non-Executive Director effective November 23, 2026. Dr Kreuzburg brings over 20 years of leadership in life sciences, notably transforming Sartorius AG into a major global player. His expertise in scaling businesses and executing acquisitions is expected to aid OXB's expansion across the UK, France, and the US. This appointment aligns with OXB's strategy to strengthen its position in viral vector manufacturing and innovation-led therapies.

OXB's appointment of Joachim Kreuzburg as Independent Non-Executive Director coincides with a health sector where 95 of 150 US stocks rose on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 16, 2026 18:11 WIB: Amneal Pharmaceuticals Inc. (AMRX) traded at USD 19.50 with a 1-day change of +1.30%, Canopy Growth Corp (CGC) at USD 0.74 with a 1-day change of +1.29% and a Pluang order activity of 100% Sell, and Nuwellis Inc (NUWE) at USD 0.56 with a 1-day change of +1.23% and a near-even Pluang order activity split.

More News

Alphabet and Meta Platforms show strong growth but face distinct risks and valuation differences for 2027.

Alphabet and Meta Platforms show strong growth but face distinct risks and valuation differences for 2027.

Alphabet and Meta Platforms both demonstrate robust revenue growth driven by digital advertising and AI integration, with Alphabet focusing on search and cloud services, and Meta on social media engagement. Alphabet reported $471.1 billion revenue an...

Market News
Bullish
8 minutes ago
Mastercard offers steady growth and stability over Coinbase's volatile crypto exposure for 2027 investments.

Mastercard offers steady growth and stability over Coinbase's volatile crypto exposure for 2027 investments.

Coinbase Global and Mastercard represent two paths in finance: crypto infrastructure versus traditional payments. Coinbase's revenue is tied to volatile crypto trading, showing a 26.6% revenue decline and a net loss of $701.6 million in the past year...

Market News
Neutral
21 minutes ago
Dec 9 key for markets: Fed rate decision, Broadcom earnings, Micron buybacks set to impact stocks.

Dec 9 key for markets: Fed rate decision, Broadcom earnings, Micron buybacks set to impact stocks.

On December 9, three major events will influence the stock market: the Federal Open Market Committee (FOMC) is expected to raise interest rates, Broadcom will report its earnings with a focus on AI semiconductor revenue, and Micron will begin a large...

Market News
Neutral
31 minutes ago
Rising rates challenge Realty Income but its strong dividend and diversification offer resilience.

Rising rates challenge Realty Income but its strong dividend and diversification offer resilience.

Realty Income, a large net-lease REIT with over 15,500 properties, faces headwinds from rising interest rates which increase borrowing costs and pressure profits. However, the company has a strong track record of increasing dividends for 32 years and...

Market News
Bullish
46 minutes ago
DICK'S Sporting Goods favored over Coupang for 2027 due to profitability and valuation despite Coupang's growth.

DICK'S Sporting Goods favored over Coupang for 2027 due to profitability and valuation despite Coupang's growth.

Coupang leads South Korea's e-commerce with strong logistics but faces losses and regulatory challenges, including a major data breach. DICK'S Sporting Goods, expanding through Foot Locker acquisition, shows strong profitability, a solid dividend, an...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App